Novel concepts in the aetiology of male reproductive impairment

The Lancet Diabetes and Endocrinology

Volumn 5, Issue 7, 2017, Pages 544-553

  Tournaye, Herman ^a   Krausz, Csilla ^b   Oates, Robert D ^c  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b UNIVERSITY OF FLORENCE   (Italy)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; REACTIVE OXYGEN METABOLITE; BIOLOGICAL MARKER;

46,XX MALE SYNDROME; AZOOSPERMIA; CHROMOSOME DELETION Y; CHROMOSOME DISORDER; CONGENITAL BILATERAL ABSENCE OF THE VAS DEFERENS; CRYPTORCHISM; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; ISODICENTRIC Y CHROMOSOME; KLINEFELTER SYNDROME; MALE; MALE GENITAL TRACT MALFORMATION; MALE INFERTILITY; OLIGOSPERMIA; PATERNAL AGE; PRIORITY JOURNAL; RETROGRADE EJACULATION; REVIEW; SPERM PRESERVATION; SPERMATOGENESIS; SPERMATOZOON ABNORMALITY; SPERMATOZOON COUNT; TESTICULAR SPERM EXTRACTION; VARICOCELE; VARICOCELECTOMY; X CHROMOSOME LINKED DISORDER; METABOLISM; PATHOLOGY; SEMEN ANALYSIS; SPERMATOZOON;

BIOMARKERS; HUMANS; INFERTILITY, MALE; MALE; SEMEN ANALYSIS; SPERMATOZOA;

EID: 85004075661     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(16)30040-7     Document Type: Review

References (98)

1. WHO. Infertility is a global public health issue. http://www.who.int/reproductivehealth/topics/infertility/perspective/en/ (accessed April 18, 2016).
2. Mascarenhas, MN, Flaxman, SR, Boerma, T, Vanderpoel, S, Stevens, GA, National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys. PLoS Med, 9, 2012, e1001356.
3. Rutstein, SO, Shah, IH, Infecundity, infertility, and childlessness in developing countries. DHS comparative reports no. 9, 2004, World Health Organization, Geneva.
4. Agarwal, A, Mulgund, A, Hamada, A, Chyatte, MR, A unique view on male infertility around the globe. Reprod Biol Endocrinol, 13, 2015, 37.
5. WHO. WHO Laboratory manual for the examination and processing of human semen, 5th edn., 2010, World Health Organization, Geneva.
6. Ventimiglia, E, Capogrosso, P, Boeri, L, et al. Infertility as a proxy of general male health: results of a cross-sectional survey. Fertil Steril 104 (2015), 48–55.
7. Bouvattier, C, Maione, L, Bouligand, J, Dodé, C, Guiochon-Mantel, A, Young, J, Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol 8 (2011), 172–182.
8. Boehm, U, Bouloux, PM, Dattani, MT, et al. Expert consensus document: European consensus statement on congenital hypogonadotropic hypogonadism—pathogenesis, diagnosis and treatment. Nat Rev Endocrinol 11 (2015), 547–564.
9. Raivio, T, Falardeau, J, Dwyer, A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 357 (2007), 863–873.
10. Pitteloud, N, Quinton, R, Pearce, S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest 117 (2007), 457–463.
11. Sykiotis, GP, Plummer, L, Hughes, VA, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A 107 (2010), 15140–15144.
12. Crowne, E, Gleeson, H, Benghiat, H, Sanghera, P, Toogood, A, Effect of cancer treatment on hypothalamic-pituitary function. Lancet Diabetes Endocrinol 3 (2015), 568–576.
13. Nieschlag, E, Vorona, E, Doping with anabolic androgenic steroids (AAS): adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord 16 (2015), 199–211.
14. O'Hara, L, Smith, LB, Androgen receptor roles in spermatogenesis and infertility. Best Pract Res Clin Endocrinol Metab 29 (2015), 595–605.
15. Owen, RC, Elkalany, OO, Kim, ED, Testosterone supplementation in men: a practical guide for the gynecologist and obstetrician. Curr Opin Obstet Gynecol 27 (2015), 258–264.
16. Vuong, C, Van Uum, SHM, O'Dell, LE, Lutfy, K, Friedman, TC, The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 31 (2010), 98–132.
17. Fronczak, CM, Kim, ED, Barqawi, AB, The insults of illicit drug use on male infertility. J Androl 33 (2012), 515–528.
18. Caires, K, Broady, J, McLean, D, Maintaining the male germline: regulation of spermatogonial stem cells. J Endocrinol 205 (2010), 133–145.
19. Varner, DD, Odyssey of the spermatozoon. Asian J Androl 17 (2015), 522–528.
20. Muciaccia, B, Boitani, C, Berloco, BP, et al. Novel stage classification of human spermatogenesis based on acrosome development. Biol Reprod, 89, 2013, 60.
21. Dakouane, M, Albert, M, Bergère, M, et al. Aging and spermatogenesis: an histologic, cytogenetic and apoptosis study. Gynecol Obstet Fertil 33 (2005), 659–664.
22. Johnson, SL, Dunleavy, J, Gemmell, NJ, Nakagawa, S, Consistent age-dependent declines in human semen quality: a systematic review and meta-analysis. Ageing Res Rev 19 (2015), 22–33.
23. Werner, R, Holterhus, PM, Androgen action. Endocr Dev 27 (2014), 28–40.
24. Ivell, R, Wade, JD, Anand-Ivell, R, INSL3 as a biomarker of Leydig cell functionality. Biol Reprod, 88, 2013, 147.
25. Skaletsky, H, Kuroda-Kawaguchi, T, Minx, PJ, et al. The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423 (2003), 825–837.
26. Vogt, PH, Edelmann, A, Kirsch, S, et al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5 (1996), 933–943.
27. Krausz, C, Hoefsloot, L, Simoni, M, Tüttelmann, F for the European Academy of Andrology, European Molecular Genetics Quality Network. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions: state-of-the-art 2013. Andrology 2 (2014), 5–19.
28. Repping, S, Skaletsky, H, Lange, J, et al. Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71 (2002), 906–922.
29. Kuroda-Kawaguchi, T, Skaletsky, H, Brown, LG, et al. The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 29 (2001), 279–286.
30. Rozen, SG, Marszalek, JD, Irenze, K, et al. AZFc deletions and spermatogenic failure: a population-based survey of 20,000 Y chromosomes. Am J Hum Genet 91 (2012), 890–896.
31. Krausz, C, Degl'Innocenti, S, Nuti, F, et al. Natural transmission of USP9Y gene mutations: a new perspective on the role of AZFa genes in male fertility. Hum Mol Genet 15 (2006), 2673–2681.
32. Zhang, F, Li, L, Wang, L, et al. Clinical characteristics and treatment of azoospermia and severe oligospermia patients with Y-chromosome microdeletions. Mol Reprod Dev 80 (2013), 908–915.
33. Krausz, C, Quintana-Murci, L, McElreavey, K, Prognostic value of Y deletion analysis: what is the clinical prognostic value of Y chromosome microdeletion analysis?. Hum Reprod 15 (2000), 1431–1434.
34. Oates, RD, Silber, S, Brown, LG, Page, DC, Clinical characterization of 42 oligospermic or azoospermic men with microdeletion of the AZFc region of the Y chromosome, and of 18 children conceived via ICSI. Hum Reprod 17 (2002), 2813–2824.
35. Ghorbel, M, Gargouri Baklouti, S, Ben Abdallah, F, et al. Chromosomal defects in infertile men with poor semen quality. J Assist Reprod Genet 29 (2012), 451–456.
36. Pacenza, N, Pasqualini, T, Gottlieb, S, et al. Clinical presentation of Klinefelter's syndrome: differences according to age. Int J Endocrinol, 2012, 2012, 324835.
37. Aksglaede, L, Skakkebaek, NE, Almstrup, K, Juul, A, Clinical and biological parameters in 166 boys, adolescents and adults with nonmosaic Klinefelter syndrome: a Copenhagen experience. Acta Paediatr 100 (2011), 793–806.
38. Abdel-Razic, MM, Abdel-Hamid, IA, Elsobky, E, El-Dahtory, F, Further evidence of the clinical, hormonal and genetic heterogeneity of Klinefelter syndrome: a study of 216 infertile Egyptian patients. J Androl 33 (2012), 441–448.
39. Oates, RD, The natural history of endocrine function and spermatogenesis in Klinefelter syndrome: what the data show. Fertil Steril 98 (2012), 266–273.
40. Davis, SM, Rogol, AD, Ross, JL, Testis development and fertility potential in boys with Klinefelter syndrome. Endocrinol Metab Clin North Am 44 (2015), 843–865.
41. Greco, E, Scarselli, F, Minasi, MG, et al. Birth of 16 healthy children after ICSI in cases of non-mosaic Klinefelter syndrome. Hum Reprod 28 (2013), 1155–1160.
42. Aksglaede, L, Juul, A, Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol 168 (2013), R67–R76.
43. Maiburg, MC, Hoppenbrouwers, AC, van Stel, HF, Giltay, JC, Attitudes of Klinefelter men and their relatives towards TESE-ICSI. J Assist Reprod Genet 28 (2011), 809–814.
44. Gies, I, Tournaye, H, De Schepper, J, Attitudes of parents of Klinefelter boys and pediatricians towards neonatal screening and fertility preservation techniques in Klinefelter syndrome. Eur J Pediatr 175 (2016), 399–404.
45. Plotton, I, Giscard d'Estaing, S, Cuzin, B, et al. Preliminary results of a prospective study of testicular sperm extraction in young versus adult patients with non-mosaic 47,XXY Klinefelter syndrome. J Clin Endocrinol Metab 100 (2015), 961–967.
46. Gies, I, Oates, R, de Schepper, J, Tournaye, H, Testicular biopsy and cryopreservation for fertility preservation of pre-pubertal boys with Klinefelter syndrome: a pro/con debate. Fertil Steril 105 (2016), 249–255.
47. Aksglaede, L, Juul, A, Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol 168 (2013), 67–76.
48. Vorona, E, Zitzmann, M, Gromoll, J, Schüring, AN, Nieschlag, E, Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab 92 (2007), 3458–3465.
49. Wu, QY, Li, WW, Lit, TF, et al. Clinical, molecular and cytogenetic analysis of 46, XX testicular disorder of sex development with SRY-positive. BMC Urol, 14, 2014, 70.
50. Lange, J, Skaletsky, H, van Daalen, SK, et al. Isodicentric Y chromosomes and sex disorders as byproducts of homologous recombination that maintains palindromes. Cell 138 (2009), 855–869.
51. Kim, JW, Park, SY, Ryu, HM, et al. Molecular and clinical characteristics of 26 cases with structural Y chromosome aberrations. Cytogenet Genome Res 136 (2012), 270–277.
52. Massin, N, Bry, H, Vija, L, et al. Healthy birth after testicular extraction of sperm and ICSI from an azoospermic man with mild androgen insensitivity syndrome caused by an androgen receptor partial loss-of-function mutation. Clin Endocrinol (Oxf) 77 (2012), 593–598.
53. Lo Giacco, D, Chianese, C, Ars, E, Ruiz-Castañé, E, Forti, G, Krausz, C, Recurrent X chromosome-linked deletions: discovery of new genetic factors in male infertility. J Med Genet 51 (2014), 340–344.
54. Yatsenko, AN, Georgiadis, AP, Röpke, A, et al. X-linked TEX11 mutations, meiotic arrest, and azoospermia in infertile men. N Engl J Med 372 (2015), 2097–2107.
55. Yang, F, Silber, S, Leu, NA, et al. TEX11 is mutated in infertile men with azoospermia and regulates genome-wide recombination rates in mouse. EMBO Mol Med 7 (2015), 1198–1210.
56. WHO. The influence of varicocele on parameters of fertility in a large group of men presenting to infertility clinics. Fertil Steril 57 (1992), 1289–1293.
57. Jungwirth, A, Giwercman, A, Tournaye, H, et al., for the European Association of Urology Working Group on Male Infertility. European Association of Urology Guidelines on Male Infertility: the 2012 update. Eur Urol 62 (2012), 324–332.
58. Practice Committee of the American Society for Reproductive Medicine and the Society for Male Reproduction and Urology. Report on varicocele and infertility: a committee opinion. Fertil Steril 102 (2014), 1556–1560.
59. Kroese, AC, de Lange, NM, Collins, JA, Evers, JL, Varicocele surgery, new evidence. Hum Reprod Update, 19, 2013, 317.
60. Anderson, RA, Mitchell, TW, Kelsey, TW, Spears, N, Telfer, EE, Wallace, WH, Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol 3 (2015), 556–567.
61. Tournaye, H, Dohle, GR, Barratt, CL, Fertility preservation in men with cancer. Lancet 384 (2014), 1295–1301.
62. Picton, HM, Wyns, C, Anderson, RA, et al. A European perspective on testicular tissue cryopreservation for fertility preservation in prepubertal and adolescent boys. Hum Reprod 30 (2015), 2463–2475.
63. Samplaski, MK, Nangia, AK, Adverse effects of common medications on male infertility. Nat Rev Urol 12 (2015), 401–413.
64. Karagiannis, A, Harsoulis, F, Gonadal dysfunction in systemic diseases. Eur J Endocrinol 152 (2005), 501–513.
65. Hutson, JM, Thorup, J, Evaluation and management of the infant with cryptorchidism. Curr Opin Pediatr 27 (2015), 520–524.
66. Hart, RJ, Doherty, DA, McLachlan, RI, et al. Testicular function in a birth cohort of young men. Hum Reprod 12 (2015), 2713–2724.
67. Cobellis, G, Noviello, C, Nino, F, et al. Spermatogenesis and cryptorchidism. Front Endocrinol, 5, 2014, 63.
68. Hauser, R, Skakkebaek, NE, Hass, U, et al. Male reproductive disorders, diseases, and costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab 100 (2015), 1267–1277.
69. Krausz, C, Male infertility: pathogenesis and clinical diagnosis. Best Pract Res Clin Endocrinol Metab 25 (2011), 271–285.
70. Krausz, C, Escamilla, AR, Chianese, C, Genetics of male infertility: from research to clinic. Reproduction 150 (2015), R159–R174.
71. Juul, A, Almstrup, K, Andersson, AM, et al. Possible fetal determinants of male infertility. Nat Rev Endocrinol 10 (2014), 553–562.
72. Kläver, R, Gromoll, J, Bringing epigenetics into the diagnostics of the andrology laboratory: challenges and perspectives. Asian J Androl 16 (2014), 669–674.
73. Laurentina, SO, Beygo, J, Nordhoff, V, et al. Epigenetic germline mosaicism in infertile men. Hum Mol Genet 24 (2015), 1295–1304.
74. Coutton, C, Escoffier, J, Martinez, G, Arnoult, C, Ray, PF, Teratozoospermia: spotlight on the main genetic actors in the human. Hum Reprod Update 21 (2015), 455–485.
75. Chianese, C, Fino, MG, Riera Escamilla, A, et al. Comprehensive investigation in patients affected by sperm macrocephaly and globozoospermia. Andrology 3 (2015), 203–212.
76. De Braekeleer, M, Nguyen, MH, Morel, F, Perrin, A, Genetic aspects of monomorphic teratozoospermia: a review. J Assist Reprod Genet 32 (2015), 615–623.
77. Chansel-Debordeaux, L, Dandieu, S, Bechoua, S, Jimenez, C, Reproductive outcome in globozoospermic man: update and prospects. Andrology 3 (2015), 1022–1034.
78. Sartorius, GA, Nieschlag, E, Paternal age and reproduction. Hum Reprod Update 16 (2010), 65–79.
79. Sharma, R, Agarwal, A, Rohra, VK, Assidi, M, Abu-Elmagd, M, Turki, RF, Effects of increased paternal age on sperm quality, reproductive outcome and associated epigenetic risks to offspring. Reprod Biol Endocrinol 19 (2015), 13–35.
80. Chianese, C, Brilli, S, Krausz, C, Genomic changes in spermatozoa of the aging male. Adv Exp Med Biol 791 (2014), 13–26.
81. Abbas, HA, Rafei, RE, Charafeddine, L, Yunis, K, Effects of advanced paternal age on reproduction and outcomes in offspring. Neoreviews 16 (2015), e69–e83.
82. Goriely, A, Wilkie, AO, Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet 90 (2012), 175–200.
83. Risch, N, Reich, EW, Wishnick, MM, McCarthy, JG, Spontaneous mutation and parental age in humans. Am J Hum Genet 41 (1987), 218–248.
84. Malaspina, D, Harlap, S, Fennig, S, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 58 (2001), 361–367.
85. Reichenberg, A, Gross, R, Weiser, M, et al. Advancing paternal age and autism. Arch Gen Psychiatry 63 (2006), 1026–1032.
86. Gharagozloo, P, Aitken, RJ, The role of sperm oxidative stress in male infertility and the significance of oral antioxidant therapy. Hum Reprod 26 (2011), 1628–1640.
87. Krausz, C, Mills, C, Rogers, S, Tan, SL, Aitken, RJ, Stimulation of oxidant generation by human sperm suspensions using phorbol esters and formyl peptides: relationships with motility and fertilization in vitro. Fertil Steril 62 (1994), 599–605.
88. Cookson, MS, Witt, MA, Kimball, KT, Grantmyre, JE, Lipshultz, LI, Can semen analysis predict the presence of antisperm antibodies in patients with primary infertility?. World J Urol 13 (1995), 318–322.
89. Francavilla, F, Romano, R, Santucci, R, La Verghetta, G, D'Abrizio, P, Francavilla, S, Naturally-occurring antisperm antibodies in men: interference with fertility and implications for treatment. Front Biosci 4 (1999), e9–25.
90. Abshagen, K, Behre, HM, Cooper, TG, Nieschlag, E, Influence of sperm surface antibodies on spontaneous pregnancy rates. Fertil Steril 70 (1998), 355–356.
91. Leushuis, E, van der Steeg, JW, Steures, P, et al. Immunoglobulin G antisperm antibodies and prediction of spontaneous pregnancy. Fertil Steril 92 (2009), 1659–1665.
92. Zini, A, Fahmy, N, Belzile, E, Ciampi, A, Al-Hathal, N, Kotb, A, Antisperm antibodies are not associated with pregnancy rates after IVF and ICSI: systematic review and meta-analysis. Hum Reprod 26 (2011), 1288–1295.
93. Amdani, SN, Yeste, M, Jones, C, Coward, K, Phospholipase C zeta (PLCζ) and male infertility: clinical update and topical developments. Adv Biol Regul, 2015, 10.1016/j.jbior.2015.11.009 published online Nov 30.
94. Yu, J, Chen, Z, Ni, Y, Li, Z, CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis. Hum Reprod 27 (2012), 25–35.
95. Bombieri, C, Claustres, M, De Boeck, K, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibros 10 (2011), S86–102.
96. McCallum, T, Milunsky, J, Munarriz, R, Carson, R, Sadeghi-Nejad, H, Oates, R, Unilateral renal agenesis associated with congenital bilateral absence of the vas deferens: phenotypic findings and genetic considerations. Hum Reprod 16 (2001), 282–288.
97. Phillips, E, Carpenter, C, Oates, RD, Ejaculatory dysfunction. Neiderberger, CS, (eds.) Clinics review articles urologic clinics of North America: current management of male infertility, 2014, Elsevier, Philadelphia, PA, 115–128.
98. Le Lannou, D, Jezequel, P, Blayau, M, et al. Obstructive azoospermia with agenesis of vas deferens or with bronchiectasia (Young's syndrome): a genetic approach. Hum Reprod 10 (1995), 338–341.